Page 4 - Pharmaceutical Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharmaceutical inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharmaceutical Inc Today - Breaking & Trending Today

Ultragenyx Pharmaceutical (NASDAQ:RARE) Coverage Initiated by Analysts at Royal Bank of Canada

Royal Bank of Canada began coverage on shares of Ultragenyx Pharmaceutical (NASDAQ:RARE – Free Report) in a report released on Monday, Marketbeat.com reports. The brokerage issued an outperform rating and a $77.00 price target on the biopharmaceutical company’s stock. Several other equities analysts have also recently commented on RARE. JPMorgan Chase & Co. upped their […] ....

United States , Robertw Baird , Karah Herdman Parschauer , Royal Bank , Allspring Global Investments Holdings , Securities Exchange Commission , Covestor Ltd , Associates Corp , Cantor Fitzgerald , Jpmorgan Chase Co , Canaccord Genuity Group , Ultragenyx Pharmaceutical Inc , Ultragenyx Pharmaceutical , Free Report , Genuity Group , Moderate Buy , Get Free Report , John Richard Pinion , Exchange Commission , Herdman Parschauer , State Retirement System , Global Investments Holdings , Pharmaceutical Inc , North America , Latin America , Ultragenyx Pharmaceutical Daily ,

Ultragenyx Pharmaceutical (RARE) to Release Quarterly Earnings on Thursday

Ultragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report) will issue its quarterly earnings data after the market closes on Thursday, May 2nd. Analysts expect the company to announce earnings of ($1.73) per share for the quarter. Ultragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report) last announced its quarterly earnings data on Thursday, February 15th. The biopharmaceutical company […] ....

United States , Matthewk Fust , Cantor Fitzgerald , Royal Bank , Ultragenyx Pharmaceutical Inc , Canaccord Genuity Group , Ultragenyx Pharmaceutical Company Profile , Jpmorgan Chase Co , Ultragenyx Pharmaceutical , Get Free Report , John Richard Pinion , Director Matthew , Pharmaceutical Inc , North America , Latin America , Ultragenyx Pharmaceutical Daily , Nasdaq Rare ,